Wyeth And Progenics Provide Update On Phase 3 Clinical Trial Of...
“Preliminary findings from this international study of 542 patients are inconsistent with the clinically meaningful results demonstrated in the 65-patient phase 2 study of intravenous methylnaltrexone for the management of postoperative ileus.”
Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials Article Date: 13 Mar 2008 Wyeth Pharmaceuticals, a division of Wyeth , and Progenics Pharmaceuticals, Inc. via MediLexicon
Join the discussion below, or Read more at MediLexicon.
#1 Mar 16, 2008
There's an interesting write-up at Google Answers on the number and types of clinical trials taking place, and some of the key players involved.
It's too much to summarize here, but for anyone interested, you can check it out at:
Number and Types of Clinical Trials
Worth a look.
Add your comments below
|Earnings Preview: Pfizer to report 2Q earnings (Aug '10)||Jun '14||Gordan||17|
|Wyeth's Pristiq, A New Treatment For Major Depr... (May '08)||Jan '14||Vikkie||3|
|Wyeth's Pristiq, a New Treatment for Major Depr... (Jul '08)||Jan '14||Trixy||6|
|Lilly's Results Run the Gamut (Oct '08)||Sep '13||Hugh||2|
|Wyeth to Pay $134.5M in Hormone Drug Case (Nov '07)||Sep '13||Elliot||8|
|Wyeth hit with $134.5M judgment over hormone re... (Oct '07)||Sep '13||William||3|
|ativan untill 2003 Wyeth product (Feb '08)||Mar '13||patient||9|
Find what you want!
Search Wyeth Forum Now
Copyright © 2015 Topix LLC